Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 3089378, 9 pages
https://doi.org/10.1155/2017/3089378
Research Article

Fibroblast Growth Factor 21 Deficiency Attenuates Experimental Colitis-Induced Adipose Tissue Lipolysis

1College of Animal Science and Technology, Key Laboratory of Animal Production and Production Quality and Security, Ministry of Education, Jilin Agricultural University, Changchun, Jilin 130118, China
2Departments of Medicine, Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA
3College of Animal Science and Technology, Key Lab of Preventive Veterinary Medicine in Jilin Province, Jilin Agricultural Science and Technology University, Jilin, Jilin 132101, China
4Institute of Virology, Wenzhou University, Wenzhou, Zhejiang 325027, China
5Schools of Pharmacy and Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China
6First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China
7Institute of Military Veterinary Institute, Academy of Military Medical Science, Changchun, Jilin 130122, China
8Alcohol Research Center, University of Louisville School of Medicine, Louisville, KY 40202, USA
9Robley Rex VA Medical Center, Louisville, KY 40206, USA

Correspondence should be addressed to Weimin Luan; moc.361@7591nimiewnaul and Wenke Feng; ude.ellivsiuol@gnef.eknew

Received 11 January 2017; Revised 24 March 2017; Accepted 2 April 2017; Published 11 May 2017

Academic Editor: Cristiano Pagnini

Copyright © 2017 Liming Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Podolsky, “Inflammatory bowel disease,” The New England Journal of Medicine, vol. 347, no. 6, pp. 417–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Baumgart and W. J. Sandborn, “Crohn’s disease,” Lancet, vol. 380, no. 9853, pp. 1590–1605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Danese and C. Fiocchi, “Ulcerative colitis,” The New England Journal of Medicine, vol. 365, no. 18, pp. 1713–1725, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. C. Ling and A. M. Griffiths, “Nutrition in inflammatory bowel disease,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 3, no. 5, pp. 339–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. G. E. Wild, L. Drozdowski, C. Tartaglia, M. T. Clandinin, and A. B. Thomson, “Nutritional modulation of the inflammatory response in inflammatory bowel disease—from the molecular to the integrative to the clinical,” World Journal of Gastroenterology, vol. 13, no. 1, pp. 1–7, 2007. View at Publisher · View at Google Scholar
  6. R. Rocha, G. O. Santana, N. Almeida, and A. C. Lyra, “Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase,” The British Journal of Nutrition, vol. 101, no. 5, pp. 676–679, 2009. View at Google Scholar
  7. E. Capristo, G. Mingrone, G. Addolorato, A. V. Greco, and G. Gasbarrini, “Metabolic features of inflammatory bowel disease in a remission phase of the disease activity,” Journal of Internal Medicine, vol. 243, no. 5, pp. 339–347, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Kimmel, D. L. Brasaemle, M. McAndrews-Hill, C. Sztalryd, and C. Londos, “Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins,” Journal of Lipid Research, vol. 51, no. 3, pp. 468–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Zimmermann, J. G. Strauss, G. Haemmerle et al., “Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase,” Science, vol. 306, no. 5700, pp. 1383–1386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Villena, S. Roy, E. Sarkadi-Nagy, K. H. Kim, and H. S. Sul, “Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis,” The Journal of Biological Chemistry, vol. 279, no. 45, pp. 47066–47075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Holm and T. Osterlund, “Hormone-sensitive lipase and neutral cholesteryl ester lipase,” Methods in Molecular Biology, vol. 109, pp. 109–121, 1999. View at Google Scholar
  12. M. Karlsson, J. A. Contreras, U. Hellman, H. Tornqvist, and C. Holm, “cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases,” The Journal of Biological Chemistry, vol. 272, no. 43, pp. 27218–27223, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Greenberg, J. J. Egan, S. A. Wek, M. C. Moos Jr, C. Londos, and A. R. Kimmel, “Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 12035–12039, 1993. View at Google Scholar
  14. J. J. Egan, A. S. Greenberg, M. K. Chang, S. A. Wek, M. C. Moos Jr, and C. Londos, “Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 18, pp. 8537–8541, 1992. View at Google Scholar
  15. C. Londos, D. L. Brasaemle, C. J. Schultz et al., “On the control of lipolysis in adipocytes,” Annals of the New York Academy of Sciences, vol. 892, pp. 155–168, 1999. View at Publisher · View at Google Scholar
  16. T. Inagaki, P. Dutchak, G. Zhao et al., “Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21,” Cell Metabolism, vol. 5, no. 6, pp. 415–425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Zhao, Y. Liu, J. Xiao et al., “FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice,” Journal of Lipid Research, vol. 56, no. 8, pp. 1481–1491, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Potthoff, T. Inagaki, S. Satapati et al., “FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 26, pp. 10853–10858, 2009. View at Google Scholar
  19. K. R. Feingold, C. Grunfeld, J. G. Heuer et al., “FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis,” Endocrinology, vol. 153, no. 6, pp. 2689–2700, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Gariani, G. Drifte, I. Dunn-Siegrist, J. Pugin, and F. R. Jornayvaz, “Increased FGF21 plasma levels in humans with sepsis and SIRS,” Endocrine Connections, vol. 2, no. 3, pp. 146–153, 2013. View at Publisher · View at Google Scholar
  21. Z. Kmiec, “Cytokines in inflammatory bowel disease,” Archivum Immunologiae et Therapiae Experimentalis (Warsz), vol. 46, no. 3, pp. 143–155, 1998. View at Google Scholar
  22. V. Gross, T. Andus, I. Caesar, M. Roth, and J. Schölmerich, “Evidence for continuous stimulation of interleukin-6 production in Crohn’s disease,” Gastroenterology, vol. 102, no. 2, pp. 514–519, 1992. View at Publisher · View at Google Scholar
  23. J. Mudter and M. F. Neurath, “Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance,” Inflammatory Bowel Diseases, vol. 13, no. 8, pp. 1016–1023, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Peyrin-Biroulet, M. Chamaillard, F. Gonzalez et al., “Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander?” Gut, vol. 56, no. 4, pp. 577–583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. L. G. Teixeira, A. J. Leonel, E. C. Aguilar et al., “The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation,” Lipids in Health and Disease, vol. 10, p. 204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Arner, A. Pettersson, P. J. Mitchell, J. D. Dunbar, A. Kharitonenkov, and M. Rydén, “FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity,” FEBS Letters, vol. 582, no. 12, pp. 1725–1730, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. G. Fiorenza, S. H. Chou, and C. S. Mantzoros, “Lipodystrophy: pathophysiology and advances in treatment,” Nature Reviews. Endocrinology, vol. 7, no. 3, pp. 137–150, 2011. View at Google Scholar
  28. C. I. Kolditz and D. Langin, “Adipose tissue lipolysis,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 4, pp. 377–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Miyoshi, S. C. Souza, H. H. Zhang et al., “Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms,” The Journal of Biological Chemistry, vol. 281, no. 23, pp. 15837–15844, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Haemmerle, A. Lass, R. Zimmermann et al., “Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase,” Science, vol. 312, no. 5774, pp. 734–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. P. A. Dutchak, T. Katafuchi, A. L. Bookout et al., “Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones,” Cell, vol. 148, no. 3, pp. 556–567, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Murata, M. Konishi, and N. Itoh, “FGF21 as an endocrine regulator in lipid metabolism: from molecular evolution to physiology and pathophysiology,” Journal of Nutrition and Metabolism, vol. 2011, Article ID 981315, p. 8, 2011. View at Publisher · View at Google Scholar · View at Scopus